Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses

Thrombosis and Haemostasis

Volumn 87, Issue 2, 2002, Pages 273-276

  Liu, Miao Liang ^a   Nakaya, Shelley ^a   Thompson, Arthur R ^a  

^a PUGET SOUND BLOOD CENTER   (United States)

Author keywords

Factor VIII; Hemophilia A; Inhibitors; Mutations

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; HISTIDINE;

ALLOIMMUNITY; ARTICLE; AUTOIMMUNITY; EXON; FAMILY; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMIC FRAGMENT; HEMOPHILIA A; HETERODUPLEX ANALYSIS; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PREDICTION; PRIORITY JOURNAL; RNA SPLICING;

EID: 0036166776     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612984     Document Type: Article

References (20)

1. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A
2. Characteristic mRNA abnormality found in half the patients with severe hemophilia A is due to large DNA inversions
3. The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4
4. Factor VIII inhibitors in mild and moderate-severity haemophilia A
5. A domain mutations in 65 haemophilia A families and molecular modeling of dysfunctional factor VIII proteins
6. Modeling hemophilic factor VIII (F.VIII) C1 and C2 domain mutations into the 1.5 A human C2 domain crystal structure
7. Some factor VIII exon 14 frameshift mutations cause phenotypically moderately severe hemophilia A
8. Clinical correlates among 49 families with hemophilia A and factor VIII gene inversions
9. Factor VIII gene inversions and an XbaI polymorphism: Nonradioactive detection and clinical usage
10. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa
11. Characterization of the human factor VIII gene
12. Expression of active human factor VIII from recombinant DNA clones
13. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin
14. Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation
15. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group
16. The missense mutation Arg593-Cys is related to antibody formation in a patient with mild hemophilia A
17. Factor VIII inhibitors in two families with mild haemophilia A: Structural analysis of the mutations
18. Anti-factor VIII antibodies of hemophilic patients are frequently directed towards nonfunctional determinants and do not exhibit isotype restriction
19. Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: Identification of 14 novel mutations
20. Consequences of factor IX mutations in 26 families with haemophilia B